Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 11, 1996, Pages 3871-3876

  Hunt, P J ^a   Espiner, E A ^a   Nicholls, M G ^a   Richards, A M ^a   Yandle, T G ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP;

ADULT; ALDOSTERONE RELEASE; ARTICLE; HOMEOSTASIS; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; MALE; NATRIURESIS; PLASMA VOLUME; PRIORITY JOURNAL; RECEPTOR DENSITY; SYSTOLIC BLOOD PRESSURE;

ADULT; ALDOSTERONE; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; CYCLIC GMP; GUANYLATE CYCLASE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; NATRIURESIS; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; PLASMA VOLUME; RECEPTORS, ATRIAL NATRIURETIC FACTOR; TIME FACTORS;

EID: 0029798286     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.11.3871     Document Type: Article

References (38)

1. Richards AM, Cleland JGF, Tonolo G, et al. 1986 Plasma α natriuretic peptide in cardiac impairment. Br Med J. 293:409-412.
2. Mukoyama M, Nakao K, Hosoda K, et al. 1991 Brain natriuretic peptide as a novel cardiac hormone in humans. J Clin Invest. 87:1402-1412.
3. Kambayashi Y, Nakao K, Kimura H, et al. 1990 Biological characterization of human brain natriuretic peptide (BNP) and rat BNP: species-specific actions of BNP. Biochem Biophys Res Commun. 173:599-605.
4. Sudoh T, Kangawa K, Minamino N, Matsuo H. 1988 A new natriuretic peptide in porcine brain. Nature. 332:78-81.
5. Suga S, Nakao K, Hosoda K, et al. 1992 Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology. 130:229-239.
6. Holmes SJ, Espiner EA, Richards AM, Yandle TG, Frampton C. 1993 Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab. 76:91-96.
7. Yoshimura M, Yasue H, Morita E, et al. 1991 Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation. 84:1581-1588.
8. Espiner EA, Richards AM, Yandle TG, Nicholls MG. 1995 Natriuretic Hormones. Endocrinol Metab Clin North Am. 24:481-509.
9. Kenny AJ, Bourne A, Ingram J. 1993 Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11. Biochem J. 291:83-88.
10. Hunt PJ, Espiner EA, Richards AM, Yandle TG, Frampton C, Nicholls MG. 1995 Interactions of atrial and brain natriuretic peptides at pathophysiological levels in normal men. Am J Physiol 269:R1397-R1403.
11. Florkowski CM, Richards AM, Espiner EA, Yandle TG, Frampton C. 1994 Renal, endocrine, and hemodynamic interactions of atrial and brain natriuretic peptides in normal men. Am J Physiol 35:R1244-R1250.
12. Hunt PJ, Richards AM, Espiner EA, Nicholls MG, Yandle TG. 1994 Bioactivity and metabolism of C-type natriuretic peptide in normal man. J Clin Endocrinol Metab. 78:1428-1435.
13. Yandle TG, Richards AM, Gilbert A, Fisher S, Holmes S, Espiner EA. 1993 Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. J Clin Endocrinol Metab. 76:832-838.
14. Brenner BM, Ballermann BJ, Gunning ME, Zeidel ML. 1990 Diverse biological actions of atrial natriuretic peptide. Physiol Rev. 70:665-699.
15. Koller KJ, Goeddel DV. 1992 Molecular biology of the natriuretic peptides and their receptors. Circulation. 86:1081-1088.
16. Richards AM, McDonald D, Fitzpatrick MA, et al. 1988 Atrial natriuretic hormone has biological effects in man at physiological plasma concentrations. J Clin Endocrinol Metab. 67:1134-1139.
17. Arnal J, El Amrani A, Michel J. 1993 Atrial natriuretic factor influences in vivo plasma, lung and aortic wall cGMP concentrations differently. Eur J Pharmacol. 237:265-273.
18. Zeidel ML, Silva P, Brenner BM, Seifter JL. 1987 Cyclic GMP mediates effects of atrial peptides on medullary collecting duct cells. Am J Physiol 252:F551-F559.
19. Pidgeon GB, Richards AM, Nicholls MG, Espiner EA, Yandle TG, Frampton C. 1996 Differing metabolism and bioactivity of atrial and brain natriuretic peptides in essential hypertension. Hypertension. 27:906-913.
20. Ganguly A. 1992 Atrial natriuretic peptide-induced inhibition of aldosterone secretion: a quest for mediator(s). Am J Physiol 263:E181-E194.
21. Tuchelt H, Eschenhagen G, Bahr V, Schwietzer G, Thiede HM, Oelkers W. 1990 Role of atrial natriuretic factor in changes in the responsiveness of aldosterone to angiotensin II secondary to sodium loading and depletion in man. Clin Sci. 79:57-65.
22. Schiffrin EL, Garcia R, Konrad EM. 1993 Interactions of angiotensin II and atrial natriuretic peptide. In: Raizada MK, Phillips MI, Sumners C, eds. Cellular and molecular biology of the renin-angiotensin system. Ann Arbor: CRC Press; 433-468.
23. La Villa G, Stefani L, Lazzeri C, et al. 1995 Acute effects of physiological increments of brain natriuretic peptide in humans. Hypertension. 26:628-633.
24. Cargill RI, Struthers AD, Lipworth BJ. 1995 Comparative effects of atrial natriuretic peptide and brain natriuretic peptide on the aldosterone and pressor responses to angiotensin II in man. Clin Sci. 88:81-86.
25. Murad F. 1986 Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest. 78:1-5.
26. Oda S, Sano T, Morishita Y, Matsuda Y. 1992 Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin, II: Restoration by HS-142-1 of ANP-induced inhibition of aldosterone production in adrenal glomerulosa cells. J Pharmacol Exp Ther. 263:241-245.
27. Bahr V, Sander-Bahr C, Ardevol R, Tuchelt H, Beland B, Oelkers W. 1993 Effects of atrial natriuretic factor on the renin-aldosterone system: in vivo and in vitro studies. J Steroid Biochem Mol Biol. 45:173-178.
28. Anand-Srivastava MB, Sairam MR, Cantin M. 1990 Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system. J Biol Chem. 265:8566-8572.
29. Nawata H, Ohashi M, Haji M, et al. 1991 Atrial and brain natriuretic peptide in adrenal steroidogenesis. J Steroid Biochem Mol Biol. 40:376-379.
30. Matsuoka H, Ishii M, Sugimoto T, et al. 1985 Inhibition of aldosterone production by α-human atrial natriuretic polypeptide is associated with an increase in cGMP production. Biochem Biophys Res Commun. 127:1052-1056.
31. Barrett PQ, Isales CM. 1988 The role of cyclic nucleotides in atrial natriuretic peptide-mediated inhibition of aldosterone secretion. Endocrinology. 122: 799-808.
32. Charles CJ, Espiner EA, Richards AM, Nicholls MG, Yandle TG. 1995 Comparative bioactivity of atrial, brain and C-type natriuretic peptides in conscious sheep. Am J Physiol. 270:1324-1331.
33. Espiner EA, Nicholls MG. 1993 Renin and the control of aldosterone. In: Robertson JIS, Nicholls MG, eds, The renin and aldosterone system, Vol 1. London: Gower Medical Publishing; 33.8-33.10.
34. Richards AM. 1994 The natriuretic peptides and hypertension. J Int Med. 235:543-560.
35. Richards AM, Nicholls MG, Ikram H, Webster MWI, Yandle TG, Espiner EA. 1985 Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers. Lancet. i:545-548.
36. Anderson JV, Struthers AD, Payne NN, Salter JDH, Bloom SR. 1986 Atrial natriuretic peptide inhibits the aldosterone response to angiotensin II in man. Clin Sci. 70:507-512.
37. Caputo L, Benessiano J, Boulanger CM, Levy BI. 1995 Angiotensin II increases cGMP content via endothelial angiotensin II ATI subtype receptors in the rat carotid artery. Arterioscler Thromb Vasc Biol. 15:1646-1651.
38. Marumo T, Nakaki T, Hishikawa K, et al. 1995 Natriuretic peptide-augmented induction of nitric oxide synthase through cyclic guanosine 3′,5′-monophosphate elevation in vascular smooth muscle cells. Endocrinology. 136:2135-2142.